A noted researcher at the intersection of cancer biology, neurodegeneration and epigenetics, Urbain Weyemi is joining the Department of Molecular Biosciences with the help of a recruitment grant from the Cancer Prevention and Research Institute of Texas (CPRIT). We connected with Weyemi as he makes the move from Johns Hopkins University to The University of Texas at Austin.
An associate professor of molecular biosciences at the University of Texas at Austin is one of two individuals this year to receive a Sustaining Outstanding Achievement in Research (SOAR) award from the National Institute of Dental and Craniofacial Research. Johann Eberhart was awarded the eight-year, $7.6 million grant to study the genetic and environmental causes of human birth defects of the head and face, which now occur in up to 5% of all births.
A team of undergraduate researchers involved with the Department of Molecular Biosciences received awards in two categories at the 2019 International Genetically Engineered Machine (iGEM) Jamboree, the largest showcase of synthetic biology innovations in the world.
Biologists at the University of Texas at Austin have discovered one of the key processes that let plants know when the time is right to grow and develop from seeds. The findings, published in Nature Communications, could enable future advances to improve crop yields and develop plants that can withstand a changing climate or even grow in the shade.
On a clear day on the beach in Port Aransas, Jace Tunnell noticed clear and multi-colored pellets collecting on the sand at the high tide line. On closer inspection, he discovered the pellets were tiny, round bits of plastic. And there looked to be millions of them.
Researchers at The University of Texas at Austin will head into September, childhood cancer awareness month, with nearly $5 million in new cancer prevention funding from the State of Texas.
As antibiotic-resistant bacteria, like MRSA and resistant strains of tuberculosis and gonorrhea, become more prevalent, health officials are wondering how long antibiotics will be able to hold up against their bacterial foes. And what comes next?
An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of infectious disease deaths in infants, has shown early promise in a Phase 1 human clinical trial. A team of researchers, including The University of Texas at Austin's Jason McLellan, report today in the journal Science that one dose of their vaccine candidate elicited large increases in RSV-neutralizing antibodies that were sustained for several months.
As any farmer or summer gardener knows, tiny aphids represent an enemy for most crops. The insects like many of the same plants that we rely on for food, and aphids can sometimes spread plant diseases, similar to the way mosquitos spread human diseases.
Several faculty in the College of Natural Sciences have been named the recipients of University-wide awards for their efforts to motivate and educate students at The University of Texas at Austin.
Read our publication, The Texas Scientist, a digest covering the people and groundbreaking discoveries that make the College of Natural Sciences one of the most amazing and significant places on Earth.
